位置:首页 > 蛋白库 > BCP_XANCP
BCP_XANCP
ID   BCP_XANCP               Reviewed;         160 AA.
AC   Q8P9V9;
DT   30-AUG-2017, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   25-MAY-2022, entry version 127.
DE   RecName: Full=Peroxiredoxin Bcp;
DE            EC=1.11.1.24 {ECO:0000269|PubMed:19477183, ECO:0000269|PubMed:27594682};
DE   AltName: Full=Bacterioferritin comigratory protein;
DE   AltName: Full=Thioredoxin peroxidase;
DE   AltName: Full=Thioredoxin-dependent peroxiredoxin Bcp {ECO:0000305};
GN   Name=bcp; OrderedLocusNames=XCC1738;
OS   Xanthomonas campestris pv. campestris (strain ATCC 33913 / DSM 3586 / NCPPB
OS   528 / LMG 568 / P 25).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Xanthomonadales;
OC   Xanthomonadaceae; Xanthomonas.
OX   NCBI_TaxID=190485;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33913 / DSM 3586 / NCPPB 528 / LMG 568 / P 25;
RX   PubMed=12024217; DOI=10.1038/417459a;
RA   da Silva A.C.R., Ferro J.A., Reinach F.C., Farah C.S., Furlan L.R.,
RA   Quaggio R.B., Monteiro-Vitorello C.B., Van Sluys M.A., Almeida N.F. Jr.,
RA   Alves L.M.C., do Amaral A.M., Bertolini M.C., Camargo L.E.A., Camarotte G.,
RA   Cannavan F., Cardozo J., Chambergo F., Ciapina L.P., Cicarelli R.M.B.,
RA   Coutinho L.L., Cursino-Santos J.R., El-Dorry H., Faria J.B.,
RA   Ferreira A.J.S., Ferreira R.C.C., Ferro M.I.T., Formighieri E.F.,
RA   Franco M.C., Greggio C.C., Gruber A., Katsuyama A.M., Kishi L.T.,
RA   Leite R.P., Lemos E.G.M., Lemos M.V.F., Locali E.C., Machado M.A.,
RA   Madeira A.M.B.N., Martinez-Rossi N.M., Martins E.C., Meidanis J.,
RA   Menck C.F.M., Miyaki C.Y., Moon D.H., Moreira L.M., Novo M.T.M.,
RA   Okura V.K., Oliveira M.C., Oliveira V.R., Pereira H.A., Rossi A.,
RA   Sena J.A.D., Silva C., de Souza R.F., Spinola L.A.F., Takita M.A.,
RA   Tamura R.E., Teixeira E.C., Tezza R.I.D., Trindade dos Santos M.,
RA   Truffi D., Tsai S.M., White F.F., Setubal J.C., Kitajima J.P.;
RT   "Comparison of the genomes of two Xanthomonas pathogens with differing host
RT   specificities.";
RL   Nature 417:459-463(2002).
RN   [2] {ECO:0007744|PDB:3GKK, ECO:0007744|PDB:3GKM, ECO:0007744|PDB:3GKN}
RP   X-RAY CRYSTALLOGRAPHY (1.47 ANGSTROMS), DISULFIDE BOND, FUNCTION, CATALYTIC
RP   ACTIVITY, SUBUNIT, AND MUTAGENESIS OF CYS-48 AND CYS-84.
RX   PubMed=19477183; DOI=10.1016/j.jmb.2009.05.030;
RA   Liao S.J., Yang C.Y., Chin K.H., Wang A.H., Chou S.H.;
RT   "Insights into the alkyl peroxide reduction pathway of Xanthomonas
RT   campestris bacterioferritin comigratory protein from the trapped
RT   intermediate-ligand complex structures.";
RL   J. Mol. Biol. 390:951-966(2009).
RN   [3] {ECO:0007744|PDB:5IM9, ECO:0007744|PDB:5IMA, ECO:0007744|PDB:5IMC}
RP   X-RAY CRYSTALLOGRAPHY (1.04 ANGSTROMS) OF 2-160, DISULFIDE BOND, CATALYTIC
RP   ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=27594682; DOI=10.1016/j.str.2016.07.012;
RA   Perkins A., Parsonage D., Nelson K.J., Ogba O.M., Cheong P.H., Poole L.B.,
RA   Karplus P.A.;
RT   "Peroxiredoxin catalysis at atomic resolution.";
RL   Structure 24:1668-1678(2016).
CC   -!- FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of
CC       hydrogen peroxide and organic hydroperoxides to water and alcohols,
CC       respectively. Plays a role in cell protection against oxidative stress
CC       by detoxifying peroxides and as sensor of hydrogen peroxide-mediated
CC       signaling events. {ECO:0000269|PubMed:19477183}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-dithiol + a hydroperoxide = [thioredoxin]-
CC         disulfide + an alcohol + H2O; Xref=Rhea:RHEA:62620, Rhea:RHEA-
CC         COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:30879, ChEBI:CHEBI:35924,
CC         ChEBI:CHEBI:50058; EC=1.11.1.24;
CC         Evidence={ECO:0000269|PubMed:19477183, ECO:0000269|PubMed:27594682};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=786 uM for H(2)O(2) {ECO:0000269|PubMed:27594682};
CC         KM=1840 uM for cumene hydroperoxide {ECO:0000269|PubMed:27594682};
CC         KM=293 uM for TrxA (using H(2)O(2) as substrate)
CC         {ECO:0000269|PubMed:27594682};
CC         KM=414 uM for TrxA (using cumene hydroperoxide as substrate)
CC         {ECO:0000269|PubMed:27594682};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19477183}.
CC   -!- MISCELLANEOUS: The active site is a conserved redox-active cysteine
CC       residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic
CC       attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to
CC       cysteine sulfenic acid (C(P)-SOH), which then reacts with another
CC       cysteine residue, the resolving cysteine (C(R)), to form a disulfide
CC       bridge. The disulfide is subsequently reduced by an appropriate
CC       electron donor to complete the catalytic cycle. In this atypical 2-Cys
CC       peroxiredoxin, C(R) is present in the same subunit to form an
CC       intramolecular disulfide. The disulfide is subsequently reduced by
CC       thioredoxin. {ECO:0000305|PubMed:19477183}.
CC   -!- SIMILARITY: Belongs to the peroxiredoxin family. BCP/PrxQ subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE008922; AAM41029.1; -; Genomic_DNA.
DR   RefSeq; NP_637105.1; NC_003902.1.
DR   RefSeq; WP_011036912.1; NC_003902.1.
DR   PDB; 3GKK; X-ray; 1.83 A; A=1-160.
DR   PDB; 3GKM; X-ray; 1.53 A; A=1-160.
DR   PDB; 3GKN; X-ray; 1.47 A; A/B=1-160.
DR   PDB; 5IM9; X-ray; 1.10 A; A=2-160.
DR   PDB; 5IMA; X-ray; 1.04 A; A=2-160.
DR   PDB; 5IMC; X-ray; 1.05 A; A=2-160.
DR   PDB; 5IMD; X-ray; 1.16 A; A=2-160.
DR   PDB; 5IMF; X-ray; 1.04 A; A=2-160.
DR   PDB; 5IMV; X-ray; 1.05 A; A=2-160.
DR   PDB; 5IMZ; X-ray; 1.10 A; A=2-160.
DR   PDB; 5INY; X-ray; 1.04 A; A=2-160.
DR   PDB; 5IO0; X-ray; 1.30 A; A=2-160.
DR   PDB; 5IO2; X-ray; 1.20 A; A=2-160.
DR   PDB; 5IOW; X-ray; 1.35 A; A=2-160.
DR   PDB; 5IOX; X-ray; 1.30 A; A=1-160.
DR   PDB; 5IPG; X-ray; 1.35 A; A=1-160.
DR   PDB; 5IPH; X-ray; 1.30 A; A=2-160.
DR   PDBsum; 3GKK; -.
DR   PDBsum; 3GKM; -.
DR   PDBsum; 3GKN; -.
DR   PDBsum; 5IM9; -.
DR   PDBsum; 5IMA; -.
DR   PDBsum; 5IMC; -.
DR   PDBsum; 5IMD; -.
DR   PDBsum; 5IMF; -.
DR   PDBsum; 5IMV; -.
DR   PDBsum; 5IMZ; -.
DR   PDBsum; 5INY; -.
DR   PDBsum; 5IO0; -.
DR   PDBsum; 5IO2; -.
DR   PDBsum; 5IOW; -.
DR   PDBsum; 5IOX; -.
DR   PDBsum; 5IPG; -.
DR   PDBsum; 5IPH; -.
DR   AlphaFoldDB; Q8P9V9; -.
DR   SMR; Q8P9V9; -.
DR   STRING; 340.xcc-b100_2523; -.
DR   DrugBank; DB04640; Naphthalene-2,6-disulfonic acid.
DR   EnsemblBacteria; AAM41029; AAM41029; XCC1738.
DR   KEGG; xcc:XCC1738; -.
DR   PATRIC; fig|190485.4.peg.1853; -.
DR   eggNOG; COG1225; Bacteria.
DR   HOGENOM; CLU_042529_14_1_6; -.
DR   OMA; RVVVYFY; -.
DR   EvolutionaryTrace; Q8P9V9; -.
DR   Proteomes; UP000001010; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0008379; F:thioredoxin peroxidase activity; IBA:GO_Central.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IBA:GO_Central.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antioxidant; Disulfide bond; Oxidoreductase; Peroxidase;
KW   Redox-active center; Reference proteome.
FT   CHAIN           1..160
FT                   /note="Peroxiredoxin Bcp"
FT                   /id="PRO_0000441071"
FT   DOMAIN          4..159
FT                   /note="Thioredoxin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00691"
FT   ACT_SITE        48
FT                   /note="Cysteine sulfenic acid (-SOH) intermediate"
FT                   /evidence="ECO:0000305|PubMed:19477183,
FT                   ECO:0000305|PubMed:27594682"
FT   DISULFID        48..84
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000269|PubMed:19477183,
FT                   ECO:0000269|PubMed:27594682, ECO:0007744|PDB:3GKK,
FT                   ECO:0007744|PDB:5IOX"
FT   MUTAGEN         48
FT                   /note="C->A: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19477183"
FT   MUTAGEN         84
FT                   /note="C->S: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19477183"
FT   HELIX           10..14
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          17..19
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   HELIX           28..30
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          35..39
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   HELIX           46..57
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   HELIX           59..64
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          68..74
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   HELIX           77..87
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          93..95
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   HELIX           100..104
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          108..113
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          116..121
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          124..128
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   STRAND          134..140
FT                   /evidence="ECO:0007829|PDB:5IMA"
FT   HELIX           146..157
FT                   /evidence="ECO:0007829|PDB:5IMA"
SQ   SEQUENCE   160 AA;  17278 MW;  7DC8B47B3D7442CF CRC64;
     MTDAVLELPA ATFDLPLSLS GGTQTTLRAH AGHWLVIYFY PKDSTPGCTT EGLDFNALLP
     EFDKAGAKIL GVSRDSVKSH DNFCAKQGFA FPLVSDGDEA LCRAFDVIKE KNMYGKQVLG
     IERSTFLLSP EGQVVQAWRK VKVAGHADAV LAALKAHAKQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024